Recently, Laviana Pharma (Cangzhou) Co., Ltd. has been awarded the 'EcoVadis Gold' certification by the international authoritative corporate sustainability assessment organization EcoVadis in its latest rating, recognizing its outstanding performance in the four core areas of environment, labor and human rights, business ethics, and sustainable procurement. Its overall ranking has entered the top 5% of all assessed companies globally.

For a long time, Laviana Pharma has taken 'Respect People, Sustainable Science, Team Work, Market Oriented, Accelerate Development' as its core values, deeply integrating sustainable development into the company's strategy and daily operations, establishing a unique sustainable development strategy system. The company has established a comprehensive system covering environmental management, occupational health and safety, business ethics, and sustainable procurement, and has obtained authoritative certifications such as ISO14001 (environment), ISO45001 (occupational health and safety), and ISO9001 (quality), building a standardized sustainable development framework. Additionally, LVT's bilingual Chinese and English ESG sustainable development report released in 2025 systematically presents the company's initiatives and achievements in governance supervision, risk management, and continuous improvement, demonstrating its transparency and responsibility on the path of sustainable development.

According to reports, EcoVadis is a global leading sustainable development rating platform, whose assessments are based on international standards such as the United Nations Global Compact's Ten Principles, the International Labour Organization Conventions, the Global Reporting Initiative Standards, and ISO 26000. It has become an important reference for global enterprises to screen suppliers and manage risks. Laviana Pharma's ranking in the top 5% globally this time fully demonstrates that its comprehensive management level in environmental, social, and governance (ESG) fields has been internationally recognized, further solidifying its position as a trusted partner for global clients.

On the R&D side, Laviana Pharma consistently adheres to the green and low-carbon concept, continuously increasing R&D investment, establishing an environmental laboratory, and focusing on the layout of green technology platforms such as microreactors and enzyme catalysis. These innovative technologies not only accelerate the new drug R&D process for customers but also reduce material consumption and waste emissions from the source, fulfilling the commitment to 'sustainable development'. Through technological innovation, Laviana Pharma is dedicated to reducing the environmental footprint of new drug R&D, creating long-term value for customers and society.

At the production end, Laviana Pharma highly values the impact of operations on the environment and is committed to creating an environmentally friendly business model. The company embeds the concept of sustainable development in the hearts of every employee through enhanced environmental awareness campaigns. During the production process, Laviana Pharma continuously optimizes its processes to improve energy efficiency, reduce emissions of 'three wastes,' and ensure that production and business activities comply with strict environmental standards.

Receiving the EcoVadis Gold Certification this time is a high recognition of the company's long-term commitment to sustainable development strategy. This is not only an honor but also a responsibility. In the future, we will continue to deepen the sustainable development strategy, empower green R&D with technological innovation, and work with industry partners and upstream and downstream ecosystems to continuously improve sustainable development capabilities, contributing to achieving high-quality development goals and promoting the green development of the global pharmaceutical industry.